90 related articles for article (PubMed ID: 7353036)
1. Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin.
Belew M; Gerdin B; Lindeberg G; Porath J; Saldeen T; Wallin R
Biochim Biophys Acta; 1980 Feb; 621(2):169-78. PubMed ID: 7353036
[No Abstract] [Full Text] [Related]
2. Vasoactive peptides derived from degradation of fibrinogen and fibrin.
Saldeen T
Ann N Y Acad Sci; 1983 Jun; 408():424-37. PubMed ID: 6575698
[No Abstract] [Full Text] [Related]
3. Structure-activity studies on synthetic analogs to vasoactive peptides derived from human fibrinogen.
Belew M; Gerdin B; Larsson LE; Lindeberg G; Ragnarsson U; Saldeen T; Wallin R
Biochim Biophys Acta; 1980 Sep; 632(1):87-94. PubMed ID: 7417520
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for microvascular permeability-increasing ability of peptides. Studies on analogues of a fibrinogen pentapeptide fragment.
Gerdin B; Lindeberg G; Ragnarsson U; Saldeen T; Wallin R
Biochim Biophys Acta; 1983 Jun; 757(3):366-70. PubMed ID: 6849982
[TBL] [Abstract][Full Text] [Related]
5. Effect of a fibrin(ogen)-derived vasoactive peptide on polymorphonuclear leukocyte emigration.
Saldeen K; Christie N; Nelson WR; Movat HZ
Thromb Res; 1985 Jan; 37(1):85-9. PubMed ID: 2984802
[TBL] [Abstract][Full Text] [Related]
6. A peptide formed by fibrinolysis increases microvascular permeability and inhibits angiotensin converting enzyme.
Saldeen T; Ryan JW; Ragnarsson U
Adv Exp Med Biol; 1983; 156 (Pt B)():829-34. PubMed ID: 6305169
[No Abstract] [Full Text] [Related]
7. Fibrin-derived vasoactive peptides release histamine.
Eriksson M; Saldeen K; Saldeen T; Strandberg K; Wallin R
Int J Microcirc Clin Exp; 1983; 2(4):337-45. PubMed ID: 6206010
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
9. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
Sueishi K; Nanno S; Tanaka K
Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme dependent and non-dependent effects of a fibrinogen-derived pentapeptide on microvascular permeability in rat skin.
Eriksson M; Gerdin B; Saldeen T
Ups J Med Sci; 1983; 88(2):95-101. PubMed ID: 6316608
[TBL] [Abstract][Full Text] [Related]
11. Effects of proteolytic degradation products of human fibrinogen and of human factor VIII on platelet aggregation and vascular permeability.
Stachurska J; Lopaciuk S; Gerdin B; Saldeen T; Korościk A; Kopeć M
Thromb Res; 1979; 15(5-6):663-72. PubMed ID: 494170
[No Abstract] [Full Text] [Related]
12. [The antifibrinolytic action of the D-dimer fragment].
Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
[TBL] [Abstract][Full Text] [Related]
13. Isolation of vasoactive peptides from human fibrin and fibrinogen degraded by plasmin.
Belew M; Gerdin B; Porath J; Saldeen T
Thromb Res; 1978 Dec; 13(6):983-94. PubMed ID: 155325
[No Abstract] [Full Text] [Related]
14. Structure of fibrinogen and degradation products of fibrinogen and fibrin.
Gaffney PJ
Br Med Bull; 1977 Sep; 33(3):245-51. PubMed ID: 143980
[No Abstract] [Full Text] [Related]
15. Effect of fibrin degradation products on microvascular permeability.
Gerdin B; Saldeen T
Thromb Res; 1978 Dec; 13(6):995-1006. PubMed ID: 749269
[No Abstract] [Full Text] [Related]
16. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
Harpel PC; Gordon BR; Parker TS
Proc Natl Acad Sci U S A; 1989 May; 86(10):3847-51. PubMed ID: 2524834
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the structure of terminal plasmin degradation products of human fibrinogen and fibrin.
Nieuwenhuizen W; Vermond A; Haverkate F
Biochim Biophys Acta; 1981 Feb; 667(2):321-7. PubMed ID: 6452172
[TBL] [Abstract][Full Text] [Related]
18. [The antiplasmin activity of the E fragments of fibrin and fibrinogen].
Rozenfel'd MA; Leonova VB; Khavkina LS
Izv Akad Nauk SSSR Biol; 1990; (4):511-8. PubMed ID: 2148755
[No Abstract] [Full Text] [Related]
19. Proceedings: Positive chronotropic effect of dialysable peptides derived from plasmin digestion of bovine fibrinogen preparations. Role of cyclic AMP.
Buckzo W; Franco R; Bianchetti G; Donati MB; de Gaetano G
Thromb Diath Haemorrh; 1975 Sep; 34(1):351-2. PubMed ID: 171797
[No Abstract] [Full Text] [Related]
20. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
